Showing results (21-30 of 90) with videos related to
Sort By:
Pageof 9
Anti-Cancer Drugs|April 1, 1991
Dipyridamole combination chemotherapy can be used safely in treating gastric cancer patientsY Sakaguchi, Y Maehara, Y Emi, et al.The Journal of Pharmacy and Pharmacology|February 1, 1997
Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents: implications in peptide delivery to the colonH Tozaki, Y Emi, E Horisaka, et al.Cancer|September 1, 1992
Hyperthermia enhances the inhibition of tumor growth by 1-(2-tetrahydrofuryl)-5-fluorouracil/uracil (1:4) in tumors in mice and humansY Emi, S Kohnoe, M Yoshida, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1991
Sarcoma-180 cells and human colorectal tumor cells under in vitro hypoxic conditions are more sensitive to mitomycin C and carboquoneT Kusumoto, Y Maehara, Y Sakaguchi, et al.Journal of Gastroenterology|May 30, 1998
Ileo-abdominal wall fistula caused by diverticulum of the ileumN Eriguchi, S Aoyagi, T Nakayama, et al.Anticancer Research|March 1, 1992
Epirubicin is equivalent to adriamycin in vitro against many cancer cells but more effective against gastric cancer cellsS Kohnoe, M Yoshida, I Takahashi, et al.Anti-Cancer Drugs|April 1, 1991
The microtiter SDI test is more advantageous than the SDI test for assessing the chemosensitivity of human tumor cellsS Kohnoe, Y Emi, Y Sakaguchi, et al.Oncology|January 1, 1990
Detection of DNA strand breaks in HeLa cells in vitro and in mouse sarcoma 180 cells in vivo induced by an alkylating agent, carboquone, using in situ nick translationY Maehara, H Anai, Y Sakaguchi, et al.Oncology|January 1, 1992
Cytotoxicity of mitomycin C and carboquone combined with hyperthermia against hypoxic tumor cells in vitroY Sakaguchi, S Kohnoe, Y Emi, et al.Anticancer Research|November 1, 1992
Intracellular accumulation of free calcium in mouse tumor cells exposed to anticancer drugsS Kohnoe, Y Maehara, Y Emi, et al.Pageof 9